Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (101-110 of 227) with videos related to

Pageof 23
Sort By:
Antiviral Therapy|March 9, 2005
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individualsGiorgio Antonucci, Enrico Girardi, Alessandro Cozzi-Lepri, et al.
International Journal of Antimicrobial Agents|July 22, 2021
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapyRoberta Gagliardini, Nicola Gianotti, Franco Maggiolo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 24, 2019
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort StudySebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Antiviral Therapy|October 26, 2011
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcomeAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2014
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failureGabriella Rozera, Isabella Abbate, Emanuela Giombini, et al.
Antiviral Therapy|March 8, 2006
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapyMariacarmela Solmone, Enrico Girardi, Eleonora Lalle, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA StudyWendy P Bannister, Alessandro Cozzi-Lepri, Bonaventura Clotet, et al.
Plos One|November 1, 2017
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general populationAntonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, et al.
Journal of Internal Medicine|November 13, 2024
Incidence and predictors of clinical failure after early treatment for mild-to-moderate COVID-19 in high-risk individuals: A multicentric cohort studyIlaria Mastrorosa, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2016
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized TherapyAntonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, et al.
Pageof 23

Showing results (101-110 of 227) with videos related to

Sort By:
Pageof 23
Antiviral Therapy|March 9, 2005
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individualsGiorgio Antonucci, Enrico Girardi, Alessandro Cozzi-Lepri, et al.
International Journal of Antimicrobial Agents|July 22, 2021
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapyRoberta Gagliardini, Nicola Gianotti, Franco Maggiolo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 24, 2019
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort StudySebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Antiviral Therapy|October 26, 2011
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcomeAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Enrico Girardi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2014
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failureGabriella Rozera, Isabella Abbate, Emanuela Giombini, et al.
Antiviral Therapy|March 8, 2006
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapyMariacarmela Solmone, Enrico Girardi, Eleonora Lalle, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA StudyWendy P Bannister, Alessandro Cozzi-Lepri, Bonaventura Clotet, et al.
Plos One|November 1, 2017
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general populationAntonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, et al.
Journal of Internal Medicine|November 13, 2024
Incidence and predictors of clinical failure after early treatment for mild-to-moderate COVID-19 in high-risk individuals: A multicentric cohort studyIlaria Mastrorosa, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2016
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized TherapyAntonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, et al.
Pageof 23